However, these researchers did not evaluate the role TGF-β plays in their model of tumorigenesis and therefore future research will be directed identifying how loss of SFRP1 together with TGF-β1, EGR2 upregulation, and additional tumor initiating pathways promote mammary carcinogenesis. This evidence concerns the gene EGR2 and neoplasm.